NovoCure Limited (NVCR)
NASDAQ: NVCR · Real-Time Price · USD
15.98
-0.44 (-2.68%)
Jul 17, 2026, 11:49 AM EDT - Market open
NovoCure Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 674.41 | 655.35 | 605.22 | 509.34 | 537.84 | 535.03 | |
Revenue Growth (YoY) | 8.48% | 8.28% | 18.82% | -5.30% | 0.53% | 8.23% |
Cost of Revenue | 167.29 | 166.88 | 137.18 | 128.28 | 114.87 | 114.88 |
Gross Profit | 507.13 | 488.47 | 468.04 | 381.06 | 422.97 | 420.15 |
Selling, General & Admin | 461.38 | 417.73 | 428.89 | 390.87 | 306.41 | 263.18 |
Research & Development | 229.1 | 224.54 | 209.65 | 223.06 | 206.09 | 201.3 |
Total Operating Expenses | 690.48 | 642.27 | 638.54 | 613.93 | 512.5 | 464.49 |
Operating Income | -183.36 | -153.8 | -170.5 | -232.87 | -89.52 | -44.33 |
Total Non-Operating Income (Expense) | 8.7 | 17.55 | 39.33 | 41.13 | -7.68 | 7.74 |
Pretax Income | -175.21 | -136.25 | -131.16 | -191.74 | -81.85 | -52.08 |
Provision for Income Taxes | -2.17 | -0.02 | 37.47 | 15.3 | 10.69 | 6.28 |
Net Income | -173.05 | -136.23 | -168.63 | -207.04 | -92.53 | -58.35 |
Net Income to Common | -173.05 | -136.23 | -168.63 | -207.04 | -92.53 | -58.35 |
Shares Outstanding (Basic) | 112 | 111 | 108 | 106 | 105 | 104 |
Shares Outstanding (Diluted) | 112 | 111 | 108 | 106 | 105 | 104 |
Shares Change (YoY) | 3.49% | 3.37% | 1.36% | 1.65% | 0.24% | -4.58% |
EPS (Basic) | -1.53 | -1.22 | -1.56 | -1.95 | -0.88 | -0.60 |
EPS (Diluted) | -1.53 | -1.22 | -1.56 | -1.95 | -0.88 | -0.60 |
Free Cash Flow | -48.07 | -75.68 | -69.22 | -100.43 | 9.43 | 58.59 |
Free Cash Flow Growth | - | - | - | - | -83.90% | -30.40% |
Free Cash Flow Per Share | -0.43 | -0.68 | -0.64 | -0.94 | 0.09 | 0.56 |
Gross Margin | 75.20% | 74.54% | 77.33% | 74.81% | 78.64% | 78.53% |
Operating Margin | -27.19% | -23.47% | -28.17% | -45.72% | -16.64% | -8.29% |
Profit Margin | -25.66% | -20.79% | -27.86% | -40.65% | -17.20% | -10.91% |
FCF Margin | -7.13% | -11.55% | -11.44% | -19.72% | 1.75% | 10.95% |
EBITDA | -167.91 | -139.15 | -159.26 | -221.9 | -78.9 | -34.08 |
EBITDA Margin | -24.90% | -21.23% | -26.31% | -43.57% | -14.67% | -6.37% |
EBIT | -183.36 | -153.8 | -170.5 | -232.87 | -89.52 | -44.33 |
EBIT Margin | -27.19% | -23.47% | -28.17% | -45.72% | -16.64% | -8.29% |
Effective Tax Rate | 1.24% | 0.02% | -28.56% | -7.98% | -13.06% | -12.05% |